title: Second study on valsartan is threatened with retraction over alleged data manipulation.
authors.forename: Chris
authors.initials: C
authors.lastname: Mahony
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D010818:Practice Patterns, Physicians'; D012180:Retraction of Publication as Topic; D013777:Tetrazoles / Q000009:adverse effects*; D014633:Valine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000068756:Valsartan
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine